Plasma tau in Alzheimer disease

OBJECTIVE: To test whether plasma tau is altered in Alzheimer disease (AD) and whether it is related to changes in cognition, CSF biomarkers of AD pathology (including β-amyloid [Aβ] and tau), brain atrophy, and brain metabolism. METHODS: This was a study of plasma tau in prospectively followed pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattsson, Niklas, Zetterberg, Henrik, Janelidze, Shorena, Insel, Philip S., Andreasson, Ulf, Stomrud, Erik, Palmqvist, Sebastian, Baker, David, Tan Hehir, Cristina A., Jeromin, Andreas, Hanlon, David, Song, Linan, Shaw, Leslie M., Trojanowski, John Q., Weiner, Michael W., Hansson, Oskar, Blennow, Kaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089525/
https://www.ncbi.nlm.nih.gov/pubmed/27694257
http://dx.doi.org/10.1212/WNL.0000000000003246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5089525/
https://www.ncbi.nlm.nih.gov/pubmed/27694257
http://dx.doi.org/10.1212/WNL.0000000000003246

Ejemplares similares